Health Care & Life Sciences » Biotechnology | Cara Therapeutics Inc.

Cara Therapeutics Inc.

Cara Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
39.29 M
Public Float
27.93 M
Cara Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.11
Market Cap
$866.99 M
Shares Outstanding
39.75 M
Public Float
34.8 M

Profile

Address
4 Stamford Plaza
Stamford Connecticut 06902
United States
Employees -
Website http://www.caratherapeutics.com
Updated 07/08/2019
CARA Therapeutics, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T.

Financials

View All
Created with Highcharts 5.0.14Cara Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.3 0723 07217 74517 74524 69024 69057 28057 28058 12558 12574 01374 013201320142015201620172018020k40k60k80k
Created with Highcharts 5.0.14Cara Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.11 96411 9643 1773 1773 8033 803868691191113 46913 46920132014201520162017201802.5k5k7.5k10k12.5k15k

Derek T. Chalmers
President, Chief Executive Officer & Director
Chris Posner
Director